Dementia

Tyrese Boyd 10/14/16 health -6

Causes/symptom

Alzheimer's disease,Vascular disease,Lewy body Dementia,Huntington's disease,HIV,

Head Trauma,Parkinson's,Frontal lobe Dementia.

Problems with Language,Memory loss,Disorientation,Personality changes,

Alzheimer

a disease of the brain that causes people to slowly lose their memory and mental abilities as they grow old

Age/Gender Tendencies

Dementia is 'young onset' when it affects people of working age, usually between 30 and 65 years old. It is also referred to as 'early onset' or 'working-age' dementia.


The incidence of vascular dementia is higher for men than for women in all age groups.

Slogan

3 Agencies

1. U.S. MEMORY care

2. Avalon Memory care since 1995

3. In Home Health care

Alzheimer's Disease Short Film - Video - Patient - Dementia Short Film

background about Dementia

Doctors may be able to estimate which people with Parkinson’s disease are more likely to develop dementia by using assessment tools, say researchers in the March 25 issue of JAMA Neurology. Catching signs of cognitive impairment early may offer people a chance to halt the onset of dementia.

It is estimated that at any one time, one quarter to one third of people with Parkinson’s disease have symptoms of mild cognitive impairment (MCI). Generally, these changes are mild and will not interfere with a person’s ability to function. But researchers were not sure if, as happens in Alzheimer’s disease, this mild form of impairment was predictive of more severe dementia. Last March, the Movement Disorder Society Task Force developed a uniform list of criteria to help doctors detect mild cognitive impairment in people with PD1. It includes tests to measure attention span, verbal memory, spatial skills, and executive functions such as the ability to plan in advance. But the criteria had not yet been proven as useful for detecting MCI or predicting dementia in people with Parkinson’s.

A research team led by Kenn Pedersen, M.D., Ph.D., at the Norwegian Center for Movement Disorders in Bergen put the MDS Task Force’s criteria to the test. As part of an ongoing study, Dr. Pedersen’s team followed 182 Norwegians who had recently been diagnosed with PD, did not have dementia, and were not yet on medication. Each person had been tested for the presence of mild cognitive impairment at the time of diagnosis. Dr. Pedersen and his colleagues then tested each participant again, during the first and third year of their study, using the new criteria.